OAM
CRL icon

OP Asset Management’s Charles River Laboratories CRL Stock Holding History

OP Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,340
Closed -$404K – 777
2026
Q1 		$404K Sell
2,340
-1,652
-41% -$306K ﹤0.01% 688
2025
Q4 		$796K Buy
3,992
+1,575
+65% +$286K 0.01% 612
2025
Q3 		$378K Buy
+2,417
New +$384K ﹤0.01% 697

Other funds holding CRL

CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

OP Asset Management's CRL Position: Q2 2026 in Review

OP Asset Management sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 2,340 shares — an estimated $404K sold.

OP Asset Management first reported a position in CRL in Q3 2025 and held it in 3 quarters. The position peaked at $796K in Q4 2025. 184 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • OP Asset Management reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
  • OP Asset Management sold 2,340 Charles River Laboratories shares in Q2 2026, an estimated $404K.
  • OP Asset Management first reported a position in Charles River Laboratories in Q3 2025 and held it in 3 quarters.
  • OP Asset Management's Charles River Laboratories position peaked at $796K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.